Skip to main content

Table 1 Demographic and clinical characteristics of the patients at baseline

From: Change in quality of life and their predictors in the long-term follow-up after group cognitive behavioral therapy for social anxiety disorder: a prospective cohort study

  Patients who entered the CBT but did not complete Patients who completed the CBT but not the 3-month FU assessments Patients who completed the the 3-month but not the 12-month FU assessments Patients who provided both FU assessments P value
Number of subjects 9 4 4 40  
Female, No. (%) 3 (33.3) 2 (50.0) 2 (50.0) 23 (57.5) 0.63
Age, years      
   Mean ± SD 27.4 ± 8.8 34.2 ± 9.3 34.2 ± 9.3 34.2 ± 8.9 0.12
   Range 18-47 18-52 18-52 18-52  
Onset of SAD, years      
   Mean ± SD 17.1 ± 4.2 19.4 ± 7.8 19.4 ± 7.8 19.6 ± 7.8 0.12
   Range 12-23 5-42 5-42 5-42  
Living situation, No (%)      0.03*
   With spouse/significant-other 0 (0.0) 1 (25.0) 2 (50.0) 20 (50.0)  
   With parents 5 (55.6) 3 (75.0) 2 (50.0) 16 (40.0)  
   Alone 4 (44.4) 0 (0.0) 0 (0.0) 4 (10.0)  
Employment      0.61
   Full-time employment 2 (22.2) 1 (25.0) 1 (25.0) 10 (25.0)  
   Full-time student 2 (22.2) 0 (0.0) 0 (0.0) 2 (5.0)  
   Part-time/homemaker/retired 3 (33.3) 2 (50.0) 3 (75.0) 23 (55.0)  
   Unemployed 2 (22.2) 1 (25.0) 0 (0.0) 6 (15.0)  
Education, No. (%)      0.61
   University 2 (22.2) 1 (25.0) 1 (25.0) 15 (37.5)  
   College 1 (11.1) 3 (75.0) 1 (25.0) 10 (25.0)  
   High school or less 6 (66.6) 0 (0.0) 2 (50.0) 15 (37.5)  
Social phobia, No. (%) generalized 8 (88.8) 4 (100.0) 3 (75.0) 34 (85.0) 0.72
Comorbidity, No. (%)      
   Mood disorders 2 (22.2) 4 (100.0) 2 (50.0) 14 (35.0) 0.05
   Anxiety disorders 1 (11.1) 1 (25.0) 0 (0.0) 4 (10.0) 0.71
Medication, No. (%)      
   Benzodiazepine 4 (44.4) 0 (0.0) 1 (25.0) 11 (27.5) 0.20
   Antidepressant 7 (77.8) 2 (50.0) 2 (50.0) 20 (50.0) 0.50
SF-36      
   Physical functioning 85.6 ± 14.7 91.3 ± 11.8 82.5 ± 22.2 88.6 ± 14.3 0.79
   Role-physical 75.0 ± 43.3 62.5 ± 43.3 56.3 ± 51.5 68.6 ± 36.6 0.87
   Bodily pain 90.3 ± 19.4 64.3 ± 29.4 66.5 ± 32.5 65.8 ± 25.3 0.08
   General health perception 47.2 ± 22.4 49.8 ± 26.3 44.3 ± 26.3 45.1 ± 22.1 0.98
   Vitality 42.2 ± 23.6 45.0 ± 5.8 20.0 ± 18.3 39.6 ± 21.1 0.28
   Social functioning 45.8 ± 23.4 56.3 ± 21.7 65.6 ± 38.7 58.7 ± 30.2 0.63
   Role-emotional 51.9 ± 44.4 50.0 ± 43.0 41.7 ± 50.0 57.3 ± 40.4 0.89
   Mental health 44.9 ± 14.9 48.0 ± 3.3 36.0 ± 15.0 47.9 ± 20.5 0.67
SPS (total) 44.0 ± 13.7 47.3 ± 28.0 34.0 ± 6.2 33.7 ± 12.5 0.08
SIAS (total) 55.3 ± 9.8 64.5 ± 26.4 51.3 ± 11.2 51.0 ± 13.3 0.29
SCL-90-R depression 1.67 ± 0.96 1.52 ± 0.75 1.35 ± 0.89 1.50 ± 0.87 0.93
  1. P-values were calculated using one-way ANOVA for continuous variables and using χ2 statistic for categorical variables.
  2. Appendices: FU, follow-up; SAD, social anxiety disorder; SCL-90-R, Symptom Checklist-90-Revised; SF-36, Short Form 36; SIAS, Social Interaction Anxiety; SPS, Social Phobia Scale
  3. (* P < 0.05, ** P < 0.005)